T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services
Scope
26DPP01283
Documents, amendments and submission instructions are on the agency's own posting.
26DPP01283
Documents, amendments and submission instructions are on the agency's own posting.